Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncalcium ion binding

CABP1 EFCAB14 GRIN1 MYL3 S100G CDH1 CETN3 FAT3 NCS1

5.30e-06749369GO:0005509
GeneOntologyMolecularFunctionretinol binding

CRABP1 CRABP2

3.73e-0416362GO:0019841
GeneOntologyMolecularFunctionmyosin heavy chain binding

STX1A MYL3

4.23e-0417362GO:0032036
GeneOntologyMolecularFunctionretinal binding

CRABP1 CRABP2

6.49e-0421362GO:0016918
GeneOntologyMolecularFunctioncalcium-dependent protein binding

CABP1 STX1A S100G

7.28e-0498363GO:0048306
GeneOntologyMolecularFunctioncarboxylic acid binding

GRIN1 RARS1 CRABP1 CRABP2

8.73e-04239364GO:0031406
GeneOntologyMolecularFunctionorganic acid binding

GRIN1 RARS1 CRABP1 CRABP2

1.09e-03254364GO:0043177
GeneOntologyMolecularFunctionretinoic acid binding

CRABP1 CRABP2

1.16e-0328362GO:0001972
GeneOntologyBiologicalProcessregulation of neuron projection development

SEMA6C SNX3 GRIN1 PTPRF CRABP2 CDH1 UBE3A FAT3 NCS1

5.95e-07612359GO:0010975
GeneOntologyBiologicalProcessneuron projection development

DOCK7 SEMA6C JUN SNX3 GRIN1 PTPRF NCKAP1 CRABP2 CDH1 UBE3A FAT3 NCS1

7.08e-0712853512GO:0031175
GeneOntologyBiologicalProcessregulation of plasma membrane bounded cell projection organization

SEMA6C SNX3 GRIN1 PTPRF NCKAP1 CRABP2 CDH1 UBE3A FAT3 NCS1

9.22e-078463510GO:0120035
GeneOntologyBiologicalProcessregulation of cell projection organization

SEMA6C SNX3 GRIN1 PTPRF NCKAP1 CRABP2 CDH1 UBE3A FAT3 NCS1

1.10e-068633510GO:0031344
GeneOntologyBiologicalProcessneuron development

DOCK7 SEMA6C JUN SNX3 GRIN1 PTPRF NCKAP1 CRABP2 CDH1 UBE3A FAT3 NCS1

2.79e-0614633512GO:0048666
GeneOntologyBiologicalProcesscell morphogenesis involved in neuron differentiation

DOCK7 SEMA6C GRIN1 PTPRF CRABP2 CDH1 UBE3A FAT3

2.84e-05748358GO:0048667
GeneOntologyBiologicalProcessnegative regulation of cell projection organization

SEMA6C PTPRF CDH1 UBE3A FAT3

4.34e-05233355GO:0031345
GeneOntologyBiologicalProcessneuron projection morphogenesis

DOCK7 SEMA6C GRIN1 PTPRF NCKAP1 CRABP2 CDH1 UBE3A

4.67e-05802358GO:0048812
GeneOntologyBiologicalProcessplasma membrane bounded cell projection morphogenesis

DOCK7 SEMA6C GRIN1 PTPRF NCKAP1 CRABP2 CDH1 UBE3A

5.41e-05819358GO:0120039
GeneOntologyBiologicalProcesscell projection morphogenesis

DOCK7 SEMA6C GRIN1 PTPRF NCKAP1 CRABP2 CDH1 UBE3A

5.75e-05826358GO:0048858
GeneOntologyBiologicalProcessaxon development

DOCK7 SEMA6C JUN GRIN1 PTPRF CRABP2 CDH1

8.62e-05642357GO:0061564
GeneOntologyBiologicalProcesscell morphogenesis

DOCK7 SEMA6C GRIN1 PTPRF NCKAP1 CRABP2 CDH1 UBE3A FAT3

1.27e-041194359GO:0000902
GeneOntologyBiologicalProcesssynapse organization

DOCK7 CABP1 GRIN1 PTPRF CDH1 UBE3A UBE3B

1.29e-04685357GO:0050808
GeneOntologyBiologicalProcesspostsynapse organization

DOCK7 GRIN1 PTPRF UBE3A UBE3B

1.74e-04313355GO:0099173
GeneOntologyBiologicalProcessnegative regulation of neuron projection development

SEMA6C CDH1 UBE3A FAT3

1.87e-04169354GO:0010977
GeneOntologyBiologicalProcessregulation of postsynapse organization

GRIN1 PTPRF UBE3A UBE3B

2.64e-04185354GO:0099175
GeneOntologyBiologicalProcessregulation of axonogenesis

SEMA6C GRIN1 CRABP2 CDH1

3.04e-04192354GO:0050770
GeneOntologyBiologicalProcessnegative regulation of cellular component organization

SEMA6C SNX3 PTPRF TERF1 CDH1 UBE3A FAT3

5.31e-04864357GO:0051129
GeneOntologyCellularComponentpostsynapse

CABP1 STX1A GRIN1 PTPRF NCKAP1 SNX6 CDH1 UBE3A NCS1 UBE3B

5.73e-0610183610GO:0098794
GeneOntologyCellularComponentglutamatergic synapse

CABP1 STX1A GRIN1 SNX6 CDH1 UBE3A NCS1 UBE3B

6.01e-05817368GO:0098978
GeneOntologyCellularComponentretromer complex

SNX3 SNX6

5.93e-0421362GO:0030904
GeneOntologyCellularComponentaxon

DOCK7 CABP1 STX1A GRIN1 PTPRF CDH1 NCS1

7.05e-04891367GO:0030424
GeneOntologyCellularComponentdistal axon

DOCK7 GRIN1 PTPRF CDH1 NCS1

8.45e-04435365GO:0150034
GeneOntologyCellularComponentpostsynaptic density

CABP1 STX1A GRIN1 PTPRF NCS1

9.93e-04451365GO:0014069
GeneOntologyCellularComponentasymmetric synapse

CABP1 STX1A GRIN1 PTPRF NCS1

1.27e-03477365GO:0032279
GeneOntologyCellularComponentpostsynaptic specialization

CABP1 STX1A GRIN1 PTPRF NCS1

1.61e-03503365GO:0099572
GeneOntologyCellularComponentneuron to neuron synapse

CABP1 STX1A GRIN1 PTPRF NCS1

1.91e-03523365GO:0098984
MousePhenoabnormal nest building behavior

GRIN1 PTPRF UBE3A UBE3B

4.56e-0645354MP:0001447
MousePhenoabnormal parental behavior

DOCK7 GRIN1 PTPRF UBE3A UBE3B

4.54e-05160355MP:0002068
DomainEF_HAND_2

CABP1 EFCAB14 MYL3 S100G CETN3 NCS1

4.79e-06231366PS50222
DomainEF_hand_dom

CABP1 EFCAB14 MYL3 S100G CETN3 NCS1

4.91e-06232366IPR002048
Domain-

CABP1 EFCAB14 MYL3 S100G CETN3 NCS1

9.63e-062613661.10.238.10
DomainEF-hand_1

CABP1 MYL3 S100G CETN3 NCS1

1.03e-05152365PF00036
DomainEF-hand-dom_pair

CABP1 EFCAB14 MYL3 S100G CETN3 NCS1

1.65e-05287366IPR011992
DomainEF_HAND_1

CABP1 EFCAB14 S100G CETN3 NCS1

4.24e-05204365PS00018
DomainEFh

CABP1 S100G CETN3 NCS1

2.35e-04158364SM00054
DomainThioredoxin

TXN2 P4HB

2.78e-0413362IPR005746
DomainEF_Hand_1_Ca_BS

CABP1 S100G CETN3 NCS1

3.47e-04175364IPR018247
DomainFatty_acid-bd

CRABP1 CRABP2

4.26e-0416362IPR000463
DomainFABP

CRABP1 CRABP2

4.26e-0416362PS00214
DomainiLBP

CRABP1 CRABP2

4.26e-0416362IPR031259
DomainThioredoxin_CS

TXN2 P4HB

4.82e-0417362IPR017937
DomainEF-hand_7

CABP1 CETN3 NCS1

5.83e-0485363PF13499
DomainTHIOREDOXIN_1

TXN2 P4HB

1.05e-0325362PS00194
DomainHECT

UBE3A UBE3B

1.23e-0327362PF00632
DomainHECTc

UBE3A UBE3B

1.23e-0327362SM00119
DomainHECT_dom

UBE3A UBE3B

1.23e-0327362IPR000569
DomainHECT

UBE3A UBE3B

1.23e-0327362PS50237
DomainThioredoxin

TXN2 P4HB

1.62e-0331362PF00085
DomainLipocalin

CRABP1 CRABP2

1.95e-0334362PF00061
DomainLipocln_cytosolic_FA-bd_dom

CRABP1 CRABP2

1.95e-0334362IPR000566
Domain-

CRABP1 CRABP2

2.07e-03353622.40.128.20
DomainCalycin

CRABP1 CRABP2

2.31e-0337362IPR012674
DomainCalycin-like

CRABP1 CRABP2

2.31e-0337362IPR011038
DomainThioredoxin_domain

TXN2 P4HB

2.83e-0341362IPR013766
DomainTHIOREDOXIN_2

TXN2 P4HB

3.10e-0343362PS51352
DomainPX

SNX3 SNX6

4.01e-0349362PF00787
DomainPX

SNX3 SNX6

4.18e-0350362PS50195
Domain-

SNX3 SNX6

4.34e-03513623.30.1520.10
DomainPhox

SNX3 SNX6

4.51e-0352362IPR001683
Pubmed

Retinoic acid-induced thymic abnormalities in the mouse are associated with altered pharyngeal morphology, thymocyte maturation defects, and altered expression of Hoxa3 and Pax1.

CRABP1 CRABP2 CDH1

1.22e-07103639894676
Pubmed

Localization of CRABP-I and CRABP-II mRNA in the early mouse embryo by whole-mount in situ hybridization: implications for teratogenesis and neural development.

CRABP1 CRABP2

1.04e-0623628075432
Pubmed

The molecular cloning and expression of two CRABP cDNAs from human skin.

CRABP1 CRABP2

1.04e-0623621309505
Pubmed

Crystal structures of cellular retinoic acid binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid.

CRABP1 CRABP2

1.04e-0623627704533
Pubmed

Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma.

JUN CDH1

1.04e-06236220977688
Pubmed

Loss of E-cadherin-mediated cell-cell contacts activates a novel mechanism for up-regulation of the proto-oncogene c-Jun.

JUN CDH1

1.04e-06236219193763
Pubmed

Assignment of the genes for cellular retinoic acid binding protein 1 (CRABP1) and 2 (CRABP2) to human chromosome band 15q24 and 1q21.3, respectively, by in situ hybridization.

CRABP1 CRABP2

1.04e-0623629154115
Pubmed

CRABP1 and CRABP2 Protein Levels Correlate with Each Other but Do Not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid.

CRABP1 CRABP2

1.04e-06236233832420
Pubmed

Molecular cloning of cDNA encoding a second cellular retinoic acid-binding protein.

CRABP1 CRABP2

1.04e-0623622166951
Pubmed

Crystal structure of cellular retinoic acid binding protein I shows increased access to the binding cavity due to formation of an intermolecular beta-sheet.

CRABP1 CRABP2

1.04e-0623627563063
Pubmed

Endogenous distribution of retinoids during normal development and teratogenesis in the mouse embryo.

CRABP1 CRABP2

1.04e-0623627780180
Pubmed

Regulation of Hepatitis C Virus Infection by Cellular Retinoic Acid Binding Proteins through the Modulation of Lipid Droplet Abundance.

CRABP1 CRABP2

1.04e-06236230728260
Pubmed

Structure-function relationships of cellular retinoic acid-binding proteins. Quantitative analysis of the ligand binding properties of the wild-type proteins and site-directed mutants.

CRABP1 CRABP2

1.04e-0623628999826
Pubmed

Expression and clinical significance of CRABP1 and CRABP2 in non-small cell lung cancer.

CRABP1 CRABP2

1.04e-06236225034531
Pubmed

LIF removal increases CRABPI and CRABPII transcripts in embryonic stem cells cultured in retinol or 4-oxoretinol.

CRABP1 CRABP2

1.04e-06236218006143
Pubmed

Mice deficient in cellular retinoic acid binding protein II (CRABPII) or in both CRABPI and CRABPII are essentially normal.

CRABP1 CRABP2

1.04e-0623627768191
Pubmed

The cellular retinoic acid binding protein I is dispensable.

CRABP1 CRABP2

1.04e-0623628090764
Pubmed

Expression of cellular retinoic acid-binding protein I and II (CRABP I and II) in embryonic mouse hearts treated with retinoic acid.

CRABP1 CRABP2

3.12e-06336221409183
Pubmed

Expression of the leucocyte common antigen-related (LAR) tyrosine phosphatase is regulated by cell density through functional E-cadherin complexes.

PTPRF CDH1

3.12e-06336212095414
Pubmed

Direct protein-protein interactions and substrate channeling between cellular retinoic acid binding proteins and CYP26B1.

CRABP1 CRABP2

3.12e-06336227416800
Pubmed

Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines.

CRABP1 CRABP2

3.12e-06336224269351
Pubmed

Cellular Retinoic-Acid Binding Protein 2 in Solid Tumor.

CRABP1 CRABP2

3.12e-06336232013828
Pubmed

Involvement of cellular retinoic acid-binding proteins I and II (CRABPI and CRABPII) and of the cellular retinol-binding protein I (CRBPI) in odontogenesis in the mouse.

CRABP1 CRABP2

3.12e-0633621663469
Pubmed

Spatio-temporal distribution of cellular retinoid binding protein gene transcripts in the developing and the adult cochlea. Morphological and functional consequences in CRABP- and CRBPI-null mutant mice.

CRABP1 CRABP2

6.24e-06436210971621
Pubmed

Mapping of the CYP2J cytochrome P450 genes to human chromosome 1 and mouse chromosome 4.

DOCK7 JUN

6.24e-0643629570962
Pubmed

miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer.

JUN CDH1

6.24e-06436223929433
Pubmed

Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.

PTPRF CDH1

6.24e-06436211245482
Pubmed

Anxa5 mediates the in vitro malignant behaviours of murine hepatocarcinoma Hca-F cells with high lymph node metastasis potential preferentially via ERK2/p-ERK2/c-Jun/p-c-Jun(Ser73) and E-cadherin.

JUN CDH1

6.24e-06436227697636
Pubmed

Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). Retinoic acid-induced expression of CRABP-II but not CRABP-I in adult human skin in vivo and in skin fibroblasts in vitro.

CRABP1 CRABP2

6.24e-0643621654334
Pubmed

Retinoid-binding protein distribution in the developing mammalian nervous system.

CRABP1 CRABP2

6.24e-0643622170099
Pubmed

Antisense oligonucleotides to CRABP I and II alter the expression of TGF-beta 3, RAR-beta, and tenascin in primary cultures of embryonic palate cells.

CRABP1 CRABP2

6.24e-0643628528505
Pubmed

Retinoid-binding proteins in the cerebellum and choroid plexus and their relationship to regionalized retinoic acid synthesis and degradation.

CRABP1 CRABP2

6.24e-0643629826179
Pubmed

Directed neural differentiation of mouse embryonic stem cells is a sensitive system for the identification of novel Hox gene effectors.

CRABP1 CRABP2

6.24e-06436221637844
Pubmed

Dynamic regulation of retinoic acid-binding proteins in developing, adult and neoplastic skin reveals roles for beta-catenin and Notch signalling.

CRABP1 CRABP2

1.04e-05536218805411
Pubmed

Postaxial polydactyly in forelimbs of CRABP-II mutant mice.

CRABP1 CRABP2

1.04e-0553627720575
Pubmed

Differential distribution patterns of CRABP I and CRABP II transcripts during mouse embryogenesis.

CRABP1 CRABP2

1.04e-0553621333403
Pubmed

High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice.

CRABP1 CRABP2

1.04e-0553628394014
Pubmed

Effects of excess vitamin A on development of cranial neural crest-derived structures: a neonatal and embryologic study.

CRABP1 CRABP2

1.04e-05536210992263
Pubmed

Maturation of ureter-bladder connection in mice is controlled by LAR family receptor protein tyrosine phosphatases.

PTPRF CDH1

1.56e-05636219273906
Pubmed

Hepatocyte migration during liver development requires Prox1.

JUN CDH1

1.56e-05636210888866
Pubmed

Retinoid signaling and the generation of regional and cellular diversity in the embryonic mouse spinal cord.

CRABP1 CRABP2

1.56e-0563628563020
Pubmed

Retinoid signaling distinguishes a subpopulation of olfactory receptor neurons in the developing and adult mouse.

CRABP1 CRABP2

1.56e-0563629590554
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

DOCK7 STX1A GRIN1 RARS1 NCKAP1 UBE3A P4HB NCS1

1.73e-05113936836417873
Pubmed

Retinoic acid receptors and cellular retinoid binding proteins. III. Their differential transcript distribution during mouse nervous system development.

CRABP1 CRABP2

2.18e-0573628397079
Pubmed

Role of the retinoic acid receptor beta (RARbeta) during mouse development.

CRABP1 CRABP2

2.18e-0573629240560
Pubmed

Chromosomal localization of the three members of the jun proto-oncogene family in mouse and man.

JUN CDH1

2.18e-0573622108401
Pubmed

Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment.

DOCK7 GRIN1

2.18e-05736225774850
Pubmed

Age-dependent retinoic acid regulation of gene expression distinguishes the cervical, thoracic, lumbar, and sacral spinal cord regions during development.

CRABP1 CRABP2

2.18e-05736210449983
Pubmed

Expression of nuclear retinoic acid receptors during mouse odontogenesis.

CRABP1 CRABP2

2.91e-0583627988794
Pubmed

The growth and expansion of meningeal lymphatic networks are affected in craniosynostosis.

CRABP2 CDH1

2.91e-05836234908123
Pubmed

Retinoic acid guides eye morphogenetic movements via paracrine signaling but is unnecessary for retinal dorsoventral patterning.

CRABP1 CRABP2

3.73e-05936216611695
Pubmed

A Spatiotemporal Requirement for Prickle 1-Mediated PCP Signaling in Eyelid Morphogenesis and Homeostasis.

JUN CDH1

3.73e-05936229450535
Pubmed

Violating the splicing rules: TG dinucleotides function as alternative 3' splice sites in U2-dependent introns.

EFCAB14 NCS1 UBE3B

3.88e-056336317672918
Pubmed

Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.

PTPRF NCKAP1 FAT3

4.66e-056736321875946
Pubmed

Mapping of PCR-based markers for mouse chromosome 4 on a backcross penetrant for the misty (m) mutation.

DOCK7 JUN

4.66e-05103627949731
Pubmed

Analysis of SUMO1-conjugation at synapses.

STX1A GRIN1

5.70e-051136228598330
Pubmed

The transcription factor Bhlhb4 is required for rod bipolar cell maturation.

CABP1 S100G

5.70e-051136215363390
Pubmed

Beta-actin is required for proper mouse neural crest ontogeny.

CRABP1 CDH1

5.70e-051136224409333
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

DOCK7 MAK16 YBX3 RARS1 P4HB CCNK TSFM MSI2

6.45e-05137136836244648
Pubmed

LTP requires a unique postsynaptic SNARE fusion machinery.

STX1A GRIN1

6.83e-051236223395379
Pubmed

Differential expression of transcripts encoding retinoid binding proteins and retinoic acid receptors during placentation of the mouse.

CRABP1 CRABP2

6.83e-05123629022057
Pubmed

Retinoic acid synthesis by ALDH1A proteins is dispensable for meiosis initiation in the mouse fetal ovary.

CRABP1 CRABP2

6.83e-051236232494737
Pubmed

Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic Acid homeostasis.

CRABP1 CRABP2

8.07e-051336212917333
Pubmed

Alternative splice variants encoding unstable protein domains exist in the human brain.

PTPRF ABCB9

8.07e-051336215491607
Pubmed

Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways.

GRIN1 NCKAP1

9.41e-051436215749123
Pubmed

MEK kinase 1 regulates c-Jun phosphorylation in the control of corneal morphogenesis.

JUN CDH1

9.41e-051436214627958
Pubmed

Functional domains of the FgfrL1 receptor.

MYL3 CDH1

9.41e-051436231923383
Pubmed

Formation and function of the meningeal arachnoid barrier around the developing mouse brain.

CRABP2 CDH1

9.41e-051436236996816
Pubmed

Understanding abnormal retinoid signaling as a causative mechanism in congenital diaphragmatic hernia.

CRABP1 CRABP2

1.08e-041536219448158
Pubmed

Microtubule-dependent apical polarization of basement membrane matrix mRNAs in mouse epithelial cells.

CDH1 P4HB

1.08e-041536238103869
Pubmed

Inactivation of LAR family phosphatase genes Ptprs and Ptprf causes craniofacial malformations resembling Pierre-Robin sequence.

PTPRF CRABP1

1.08e-041536223863482
Pubmed

Disrupting hedgehog and WNT signaling interactions promotes cleft lip pathogenesis.

CRABP1 CDH1

1.08e-041536224590292
Pubmed

Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinases.

SNX3 SNX6

1.24e-041636211279102
Pubmed

Cell autonomous roles for AP-2alpha in lens vesicle separation and maintenance of the lens epithelial cell phenotype.

STX1A CDH1

1.24e-041636218224708
Pubmed

Rac1 GTPase-deficient mouse lens exhibits defects in shape, suture formation, fiber cell migration and survival.

NCKAP1 CDH1

1.24e-041636221945075
Pubmed

Axis specification and morphogenesis in the mouse embryo require Nap1, a regulator of WAVE-mediated actin branching.

NCKAP1 CDH1

1.40e-041736216831833
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

DOCK7 YBX3 RARS1 NCKAP1 SNX6 P4HB MSI2

1.52e-04114936735446349
Pubmed

BDNF regulates spontaneous correlated activity at early developmental stages by increasing synaptogenesis and expression of the K+/Cl- co-transporter KCC2.

STX1A GRIN1

1.58e-041836212588844
Pubmed

Posterior malformations in Dact1 mutant mice arise through misregulated Vangl2 at the primitive streak.

JUN CDH1

1.58e-041836219701191
Pubmed

Transcription factor TLX1 controls retinoic acid signaling to ensure spleen development.

JUN CRABP2

1.58e-041836227214556
Pubmed

Snail family genes are required for left-right asymmetry determination, but not neural crest formation, in mice.

CRABP1 CDH1

1.58e-041836216801545
Pubmed

Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors.

GRIN1 CDH1

1.58e-041836217589506
Pubmed

Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas.

JUN CDH1

1.76e-041936217596282
Pubmed

Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.

JUN CDH1

1.96e-042036211438667
Pubmed

Glycosaminoglycan-dependent restriction of FGF diffusion is necessary for lacrimal gland development.

CRABP1 CDH1

1.96e-042036222745308
Pubmed

Loss of Sip1 leads to migration defects and retention of ectodermal markers during lens development.

NCKAP1 CDH1

2.16e-042136224161570
Pubmed

Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells.

YBX3 CDH1

2.16e-042136218353970
Pubmed

An Eya1-Notch axis specifies bipotential epibranchial differentiation in mammalian craniofacial morphogenesis.

CRABP1 CDH1

2.38e-042236229140246
Pubmed

Identification of endogenous retinoids, enzymes, binding proteins, and receptors during early postimplantation development in mouse: important role of retinal dehydrogenase type 2 in synthesis of all-trans-retinoic acid.

CRABP1 CRABP2

2.38e-042236210753524
Pubmed

E3 ubiquitin ligase RFWD2 controls lung branching through protein-level regulation of ETV transcription factors.

JUN CDH1

2.38e-042236227335464
Pubmed

Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways.

JUN P4HB

2.38e-042236215767678
Pubmed

Netrin 1 directs vascular patterning and maturity in the developing kidney.

CRABP1 CDH1

2.60e-042336237818607
Pubmed

Divergent Hox Coding and Evasion of Retinoid Signaling Specifies Motor Neurons Innervating Digit Muscles.

CRABP1 CRABP2

2.60e-042336228190640
Pubmed

Tead4 is required for specification of trophectoderm in pre-implantation mouse embryos.

JUN CDH1

2.60e-042336218083014
Pubmed

Retinoic acid, hypoxia, and GATA factors cooperatively control the onset of fetal liver erythropoietin expression and erythropoietic differentiation.

CRABP1 CRABP2

2.60e-042336215766748
Pubmed

Full-length transcriptome analysis of human retina-derived cell lines ARPE-19 and Y79 using the vector-capping method.

PTPRF CRABP1 CRABP2

2.63e-0412036321697133
Pubmed

Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.

DOCK7 MYL3 NCKAP1 UBE3A

2.70e-0430436432235678
Pubmed

Actin-related protein2/3 complex regulates tight junctions and terminal differentiation to promote epidermal barrier formation.

JUN CDH1

2.83e-042436224043783
Pubmed

Sfrp controls apicobasal polarity and oriented cell division in developing gut epithelium.

JUN CDH1

2.83e-042436219300477
Pubmed

Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney.

S100G CDH1

2.83e-042436217036046
InteractionCSNK2A2 interactions

DOCK7 MAK16 CABP1 YBX3 STX1A EFCAB14 GTF2A1L SNX6 TERF1 P4HB

3.40e-077183610int:CSNK2A2
InteractionHSD17B3 interactions

ABCB9 CDH1 NCS1

1.85e-0529363int:HSD17B3
InteractionCALM2 interactions

DOCK7 CABP1 UBE3A CETN3 UBE3B

3.10e-05206365int:CALM2
InteractionGSK3B interactions

DOCK7 JUN YBX3 RARS1 NCKAP1 CDH1 UBE3A P4HB

1.18e-04868368int:GSK3B
InteractionSPG11 interactions

BBS2 NCKAP1 SNX6

1.43e-0457363int:SPG11
InteractionLCN2 interactions

PTPRF TXN2 UBE3A P4HB

1.89e-04161364int:LCN2
InteractionUSP14 interactions

DOCK7 YBX3 RARS1 CDH1 UBE3A P4HB

2.08e-04489366int:USP14
InteractionHRAS interactions

YBX3 SNX3 GRIN1 PTPRF SNX6 CDH1 UBE3B

2.54e-04725367int:HRAS
InteractionMIR9-3 interactions

YBX3 RARS1 MSI2

2.64e-0470363int:MIR9-3
InteractionMIR29B2 interactions

YBX3 RARS1 MSI2

2.75e-0471363int:MIR29B2
InteractionHSPB9 interactions

ISCA1 NCKAP1

2.79e-0414362int:HSPB9
InteractionMIR18A interactions

YBX3 RARS1 MSI2

2.99e-0473363int:MIR18A
InteractionMIR20A interactions

YBX3 RARS1 MSI2

3.11e-0474363int:MIR20A
InteractionMIR15A interactions

YBX3 RARS1 MSI2

3.24e-0475363int:MIR15A
InteractionMIR7-3 interactions

YBX3 RARS1 MSI2

3.36e-0476363int:MIR7-3
InteractionMIR16-1 interactions

YBX3 RARS1 MSI2

3.36e-0476363int:MIR16-1
InteractionMIR199A2 interactions

YBX3 RARS1 MSI2

3.36e-0476363int:MIR199A2
InteractionMIR9-2 interactions

YBX3 RARS1 MSI2

3.50e-0477363int:MIR9-2
InteractionMIR200A interactions

YBX3 RARS1 MSI2

3.50e-0477363int:MIR200A
InteractionMIR92A1 interactions

YBX3 RARS1 MSI2

3.63e-0478363int:MIR92A1
InteractionMIR98 interactions

YBX3 RARS1 MSI2

3.63e-0478363int:MIR98
InteractionMIR451A interactions

YBX3 RARS1 MSI2

3.63e-0478363int:MIR451A
InteractionCORO1B interactions

RARS1 CRABP1 TERF1 CDH1

3.71e-04192364int:CORO1B
InteractionMIR34C interactions

YBX3 RARS1 MSI2

3.77e-0479363int:MIR34C
InteractionMIR143 interactions

YBX3 RARS1 MSI2

3.91e-0480363int:MIR143
InteractionMIR145 interactions

YBX3 RARS1 MSI2

4.06e-0481363int:MIR145
InteractionMIR10B interactions

YBX3 RARS1 MSI2

4.21e-0482363int:MIR10B
InteractionMIR106A interactions

YBX3 RARS1 MSI2

4.36e-0483363int:MIR106A
InteractionMIR7-2 interactions

YBX3 RARS1 MSI2

4.52e-0484363int:MIR7-2
InteractionMIR199A1 interactions

YBX3 RARS1 MSI2

4.52e-0484363int:MIR199A1
InteractionMIR200B interactions

YBX3 RARS1 MSI2

4.52e-0484363int:MIR200B
InteractionMIR17 interactions

YBX3 RARS1 MSI2

4.68e-0485363int:MIR17
InteractionMIR18B interactions

YBX3 RARS1 MSI2

4.68e-0485363int:MIR18B
InteractionMIR93 interactions

YBX3 RARS1 MSI2

4.68e-0485363int:MIR93
InteractionMIR9-1 interactions

YBX3 RARS1 MSI2

4.68e-0485363int:MIR9-1
InteractionMIR16-2 interactions

YBX3 RARS1 MSI2

4.68e-0485363int:MIR16-2
InteractionMIR20B interactions

YBX3 RARS1 MSI2

4.84e-0486363int:MIR20B
InteractionPARVA interactions

TXN2 CDH1 UBE3A

4.84e-0486363int:PARVA
InteractionMIR141 interactions

YBX3 RARS1 MSI2

5.18e-0488363int:MIR141
InteractionLRSAM1 interactions

ISCA1 TERF1 UBE3A

5.18e-0488363int:LRSAM1
InteractionMIR138-2 interactions

YBX3 RARS1 MSI2

5.18e-0488363int:MIR138-2
InteractionPCDHAC1 interactions

PTPRF ABCB9

5.20e-0419362int:PCDHAC1
InteractionMIR29C interactions

YBX3 RARS1 MSI2

5.35e-0489363int:MIR29C
InteractionWDR4 interactions

TERF1 UBE3A TSFM

5.35e-0489363int:WDR4
InteractionTNIK interactions

DOCK7 ZNF462 GRIN1 NCKAP1 SNX6

5.47e-04381365int:TNIK
InteractionMIR221 interactions

YBX3 RARS1 MSI2

5.53e-0490363int:MIR221
InteractionMIR1-1 interactions

YBX3 RARS1 MSI2

5.53e-0490363int:MIR1-1
InteractionSLC25A41 interactions

CETN3 NCS1 TSFM

5.53e-0490363int:SLC25A41
InteractionMIR200C interactions

YBX3 RARS1 MSI2

5.71e-0491363int:MIR200C
InteractionMIR155 interactions

YBX3 RARS1 MSI2

5.89e-0492363int:MIR155
InteractionMIR128-1 interactions

YBX3 RARS1 MSI2

5.89e-0492363int:MIR128-1
InteractionMIR214 interactions

YBX3 RARS1 MSI2

6.08e-0493363int:MIR214
InteractionMIR205 interactions

YBX3 RARS1 MSI2

6.08e-0493363int:MIR205
InteractionMIR19B2 interactions

YBX3 RARS1 MSI2

6.28e-0494363int:MIR19B2
InteractionMIRLET7F1 interactions

YBX3 RARS1 MSI2

6.28e-0494363int:MIRLET7F1
InteractionMIRLET7A2 interactions

YBX3 RARS1 MSI2

6.67e-0496363int:MIRLET7A2
InteractionMIRLET7C interactions

YBX3 RARS1 MSI2

6.88e-0497363int:MIRLET7C
InteractionMIR21 interactions

YBX3 RARS1 MSI2

6.88e-0497363int:MIR21
InteractionMIRLET7F2 interactions

YBX3 RARS1 MSI2

6.88e-0497363int:MIRLET7F2
InteractionMIR363 interactions

YBX3 RARS1 MSI2

6.88e-0497363int:MIR363
InteractionMYL4 interactions

MYL3 UBE3B

7.01e-0422362int:MYL4
InteractionMIR106B interactions

YBX3 RARS1 MSI2

7.09e-0498363int:MIR106B
InteractionMIR128-2 interactions

YBX3 RARS1 MSI2

7.30e-0499363int:MIR128-2
InteractionRNF2 interactions

YBX3 RARS1 TERF1 CDH1 UBE3A P4HB MSI2

7.40e-04866367int:RNF2
InteractionMIR19A interactions

YBX3 RARS1 MSI2

7.52e-04100363int:MIR19A
InteractionSYT7 interactions

STX1A CDH1

7.67e-0423362int:SYT7
InteractionCALM1 interactions

DOCK7 GRIN1 SNX6 UBE3A CETN3 UBE3B

7.72e-04626366int:CALM1
InteractionMIRLET7B interactions

YBX3 RARS1 MSI2

7.74e-04101363int:MIRLET7B
InteractionMIRLET7D interactions

YBX3 RARS1 MSI2

7.74e-04101363int:MIRLET7D
InteractionMIR25 interactions

YBX3 RARS1 MSI2

7.74e-04101363int:MIR25
InteractionMIRLET7A3 interactions

YBX3 RARS1 MSI2

7.96e-04102363int:MIRLET7A3
InteractionMIR15B interactions

YBX3 RARS1 MSI2

8.19e-04103363int:MIR15B
InteractionMIR7-1 interactions

YBX3 RARS1 MSI2

8.19e-04103363int:MIR7-1
InteractionNTNG1 interactions

SNX3 SNX6 TSFM

8.19e-04103363int:NTNG1
InteractionMIR19B1 interactions

YBX3 RARS1 MSI2

8.42e-04104363int:MIR19B1
InteractionMIR34A interactions

YBX3 RARS1 MSI2

8.42e-04104363int:MIR34A
InteractionATP5F1A interactions

DOCK7 JUN RARS1 PTPRF P4HB CETN3

8.66e-04640366int:ATP5F1A
InteractionMIRLET7E interactions

YBX3 RARS1 MSI2

8.90e-04106363int:MIRLET7E
InteractionSTXBP6 interactions

STX1A CDH1

9.07e-0425362int:STXBP6
InteractionPTPRQ interactions

PTPRF CDH1

9.07e-0425362int:PTPRQ
InteractionC1orf115 interactions

FAT3 NCS1

9.07e-0425362int:C1orf115
InteractionMKI67 interactions

DOCK7 MAK16 YBX3 CDH1 GRK7 TSFM

9.23e-04648366int:MKI67
InteractionMIRLET7A1 interactions

YBX3 RARS1 MSI2

9.40e-04108363int:MIRLET7A1
InteractionMACF1 interactions

JUN YBX3 ISCA1 CDH1

9.53e-04247364int:MACF1
InteractionFYN interactions

MAK16 GRIN1 PTPRF CRABP2 CDH1

9.54e-04431365int:FYN
InteractionGTF2A2 interactions

GTF2A1L TERF1

9.81e-0426362int:GTF2A2
InteractionMIR34B interactions

YBX3 RARS1 MSI2

9.91e-04110363int:MIR34B
InteractionMDM2 interactions

MAK16 JUN RARS1 CDH1 UBE3A MSI2

1.00e-03658366int:MDM2
InteractionBBS1 interactions

BBS2 UBE3A TSFM

1.02e-03111363int:BBS1
InteractionCOA5 interactions

JUN CRABP2

1.06e-0327362int:COA5
InteractionNHSL3 interactions

MAK16 NCKAP1 CDH1

1.07e-03113363int:NHSL3
InteractionMIRLET7I interactions

YBX3 RARS1 MSI2

1.10e-03114363int:MIRLET7I
GeneFamilyEF-hand domain containing

CABP1 EFCAB14 MYL3 S100G CETN3 NCS1

7.06e-07219276863
GeneFamilyFatty acid binding protein family

CRABP1 CRABP2

2.54e-0416272550
GeneFamilySorting nexins|PX-BAR domain containing

SNX3 SNX6

8.51e-0429272754
CoexpressionGSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN

RARS1 ABCB9 TXN2 UBE3A CETN3

7.65e-06200365M4454
CoexpressionRB_P107_DN.V1_DN

RARS1 TXN2 CRABP2 UBE3B

2.66e-05126364M2801
CoexpressionMATSUDA_NATURAL_KILLER_DIFFERENTIATION

DOCK7 JUN PTPRF ABCB9 CDH1 UBE3A

4.79e-05486366M18517
CoexpressionMEL18_DN.V1_DN

GTF2A1L CRABP1 CRABP2 TSFM

4.86e-05147364M2783
CoexpressionMATSUDA_NATURAL_KILLER_DIFFERENTIATION

DOCK7 JUN PTPRF ABCB9 CDH1 UBE3A

6.96e-05520366MM1008
CoexpressionHU_FETAL_RETINA_AMACRINE

CABP1 CRABP1 FAT3

9.36e-0564363M39261
CoexpressionAtlasDevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_500

ZNF462 CRABP1 CRABP2 MSI2

4.67e-0668354gudmap_developingGonad_e11.5_ovary + mesonephros_k3_500
CoexpressionAtlasDevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_1000

ZNF462 CRABP1 CRABP2 MSI2

3.15e-05110354gudmap_developingGonad_e11.5_ovary + mesonephros_k3_1000
ToppCellmetastatic_Brain-Epithelial_cells|metastatic_Brain / Location, Cell class and cell subclass

PTPRF NCKAP1 CRABP2 CDH1 P4HB

5.43e-071993655c0cd611dbf2014e0ae6ce9fe8b619ceb4006e43
ToppCellmetastatic_Brain-Epithelial_cells-Malignant_cells|metastatic_Brain / Location, Cell class and cell subclass

PTPRF NCKAP1 CRABP2 CDH1 P4HB

5.43e-0719936556df2b342c77b33299cfb407e1e05f42940f2946
ToppCellE15.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

JUN PTPRF CRABP2 CDH1

1.67e-05191364402c341b00f98e8215458766b3c219fff8dcb447
ToppCellE15.5-Epithelial-alveolar_epithelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

JUN PTPRF CRABP2 CDH1

1.70e-05192364567f4355a01aae1f2eafc16fe86d1538a62030ab
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

EFCAB14 CRABP1 CRABP2 CDH1

1.74e-0519336446d5d1f8150ebbc7f1941b96ab184491e5c1210b
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_2-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

YBX3 PTPRF CDH1 P4HB

1.88e-05197364ad6f047d003c08413264f39a30ba0f7639a257cd
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

YBX3 PTPRF CDH1 P4HB

1.88e-051973641638959d7aecb9fc5285eb7e4a3103ca437989e2
ToppCelldroplet-Mammary_Gland-nan-3m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTPRF CRABP2 CDH1 NCS1

1.88e-05197364b1c6a15bf6c0645952a7247182dc71baf4736869
ToppCellLPS_anti-TNF-Epithelial_alveolar|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

YBX3 PTPRF CDH1 P4HB

1.92e-0519836453e9ed1b19cb26be58da0f37057caca0cdfaabeb
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

YBX3 PTPRF CDH1 P4HB

1.92e-05198364f006d68e6c51923be7772eea118546a5762e8a5e
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

YBX3 PTPRF CDH1 P4HB

1.92e-0519836482bcd44f8744e7e8477fbfd871a52f3d1a8b3adc
ToppCellPSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PTPRF NCKAP1 CDH1 MSI2

1.96e-0519936458dcb0eedafa8629585dc99e53147e2287f49689
ToppCell10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

JUN YBX3 TERF1 MSI2

1.96e-05199364dd94e42b62af7cbd69c472681d3c758552694ae2
ToppCell15-Trachea-Epithelial|Trachea / Age, Tissue, Lineage and Cell class

YBX3 PTPRF CDH1 MSI2

1.96e-05199364e0099aa95cf3ec08d7688cc97f4b917fce65a7a3
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

YBX3 PTPRF CDH1 P4HB

1.96e-05199364329c381404d4972871142dd7f7ee78fbcc365aa1
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZNF462 JUN TERF1 CRABP2

1.96e-051993644217b9e66c5374461e84bdb893ab650f148286c8
ToppCellcontrol-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

YBX3 PTPRF NCKAP1 CDH1

2.00e-05200364f95bbb94e51ac28b1995026c599ec3a34e012916
ToppCellcontrol|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

YBX3 PTPRF NCKAP1 CDH1

2.00e-0520036497f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCellNS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

YBX3 PTPRF NCKAP1 CDH1

2.00e-05200364d014959891893b6d3854a471fba1dc50c6625a0a
ToppCellNS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

YBX3 PTPRF NCKAP1 CDH1

2.00e-05200364ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCellEpithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4)

S100G PTPRF CDH1

2.21e-041463634511916904c1fac252cb68e871b782207f8137b3
ToppCellP03-Epithelial-epithelial_progenitor_cell-epi_progenitor|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

2.44e-04151363fce04bce66411c21cd5d4d41375f26f1f50f3348
ToppCellP28-Epithelial-epithelial_progenitor_cell-epi_progenitor|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

2.63e-04155363be575a0096415705dba425002247289ff8f89474
ToppCellP15-Epithelial-epithelial_progenitor_cell-epi_progenitor|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

2.84e-04159363a4bfd59c53237964fc24a24de5c1925fdd01db99
ToppCell356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

ZNF462 PTPRF NCKAP1

3.00e-041623632259e9536147e9cdee772e3a30ba7d104573262c
ToppCellPND01-03-samps-Epithelial-Alveolar_epithelial-AT1|PND01-03-samps / Age Group, Lineage, Cell class and subclass

PTPRF CRABP2 CDH1

3.16e-04165363b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637
ToppCellP07-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.22e-04166363021b9344de7957762f81b09a647504b8c8289cf1
ToppCell356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

ZNF462 PTPRF NCKAP1

3.22e-0416636389e2b8453180983533faccb4275867861876d7ee
ToppCellP28-Epithelial-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.34e-0416836303c95ad3684caec7a6d581006b237cc5fa230685
ToppCell5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

JUN CRABP1 CRABP2

3.34e-0416836374d6dbf9295933acdee785af9b73a94377d15412
ToppCellP07-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.39e-0416936353e863de064d44e1d36e21fb3dbba37ae020f6e9
ToppCellP07-Epithelial-epithelial_progenitor_cell-epi_progenitor|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.39e-041693631a47a4892a5e6a69555f5332308503526e5422a7
ToppCellP07-Epithelial-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.39e-04169363ec23caecbb0d969307e33e9df8499ddcd1420305
ToppCellP15-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.45e-041703636c0619cbe2f01a6de18da0a137f92bda0cbdf075
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

S100G PTPRF CDH1

3.45e-041703634ce81608111b9ee7cb974dad2c182f38db3dcd79
ToppCellP28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.45e-04170363d0ed3a8a7ad96c05641ec409b0a69c4fb094893c
ToppCellP03-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.45e-041703633fd37e9b377d6485cea1262c31a8507d18a78514
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

S100G PTPRF CDH1

3.63e-0417336345808cf69122c16b9d2b5ffa06d15392c55954b7
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

JUN SNX3 CRABP2

3.63e-04173363a8ee017938dd4705361e6fd9a17061ab927027f4
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

JUN SNX3 CRABP2

3.63e-04173363c1e443c611e6f88ccbba6c019895437aa986414b
ToppCellP07-Epithelial|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.63e-041733638b10087a917b825809d35a2b2b349c73a2782472
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

S100G PTPRF CDH1

3.63e-041733637fa9dbcb258c3ab974490063951620e2def03db1
ToppCellP03-Epithelial-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.70e-0417436323c7fdfc73170cfc5cdee5bb7fbee0c8bbbbca07
ToppCellP07-Epithelial-alveolar_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.70e-041743632739de68e0266054694f99807cfb1f07b6bbb371
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STX1A GTF2A1L CRABP2

3.70e-04174363c58328c2f262506a4518f49f148e29874faf9171
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

S100G PTPRF CDH1

3.76e-04175363442f261a3b2c4d2523f7d4089178f8c79cac2f0f
ToppCellP28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.76e-041753638a4ed775ff973123dbcfe9c809959d11a62450c9
ToppCellP03-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

3.76e-04175363a6d9ca35d3c4b4e3889d0a69b514f63ae630da6b
ToppCellCOVID-matDC-|COVID / Condition, Cell_class and T cell subcluster

MYL3 CRABP1 CRABP2

3.76e-04175363db5e170411dfa62074c4b8311bb8c589d1c4279b
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

S100G PTPRF CDH1

3.76e-0417536335fb7735dd3355476fe60404833cb60bd066bcf1
ToppCellCOVID-matDC|COVID / Condition, Cell_class and T cell subcluster

MYL3 CRABP1 CRABP2

3.76e-04175363e2b638109c9ffd10430e6e134035622b7605ce23
ToppCellPND01-03-samps-Epithelial-Alveolar_epithelial-AT2|PND01-03-samps / Age Group, Lineage, Cell class and subclass

S100G PTPRF CDH1

3.82e-04176363ac76f2cd6c63f30b38b89b58bad2baa4dde8ce3a
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

S100G PTPRF CDH1

3.88e-041773633081ce5fc66a1bb833719d6c0e0a6fc7115eeb91
ToppCelldroplet-Marrow-nan-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JUN CDH1 FAT3

3.88e-04177363c1f838e425ebb04482829b1957e3c1347127e6de
ToppCelldroplet-Thymus-nan-24m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZNF462 NCKAP1 CRABP2

3.95e-04178363408e41c853f608965cef9111fb87fdc311cdc7a8
ToppCellP15-Epithelial|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

4.01e-04179363869d3d203e2cb88636e2f0c4476c72571ae3b5ca
ToppCelldroplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JUN PTPRF CDH1

4.01e-0417936387a69f9f83b8f0c028a4874acb238f2e079bf51f
ToppCelldroplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JUN PTPRF CDH1

4.01e-04179363dcaf2191134a586d50ebaf67dcf5b815b54a722b
ToppCellfacs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

YBX3 NCKAP1 NCS1

4.01e-041793638001db3044e8657980e24422377c4fdb0d7b323e
ToppCell3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GRIN1 CRABP1 CRABP2

4.01e-04179363228d12ed1c8dc92aefbcea4aaf7d108783c22be0
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

S100G PTPRF CDH1

4.01e-04179363bf012825e88626e59cd1deebf67c2cd269ce4829
ToppCelldroplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

S100G PTPRF CDH1

4.01e-04179363ca70a5518c5a5392e088c103e0cb44aa084f5332
ToppCelldroplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

S100G PTPRF CDH1

4.01e-04179363c451b074b04eb5d6c575c6abaedda579c6744bbf
ToppCellNS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

SEMA6C GRIN1 FAT3

4.01e-0417936365a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c
ToppCellAT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

S100G PTPRF CDH1

4.15e-04181363ed0ea67f0607073aedf153f8d1073b35e46127c3
ToppCellIIH-plasma|IIH / Condition, Cell_class and T cell subcluster

MYL3 CRABP1 CRABP2

4.15e-0418136313d1f31bcbac21aea91de74f51eed549ec61003e
ToppCellP03-Epithelial|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

4.15e-04181363de0466072f5b2ab8db3d9bab31e3205d1ff7cfb7
ToppCellP03-Epithelial-alveolar_epithelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

4.15e-04181363c3dbf8850d3812fbb770798f4cf38908db8bb92b
ToppCellIIH-plasma-|IIH / Condition, Cell_class and T cell subcluster

MYL3 CRABP1 CRABP2

4.15e-04181363140ac43dc6b89396872f908c14c89278f6d982b2
ToppCellP15-Epithelial-alveolar_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

4.15e-041813637033be0ba90556f7e5f7c0d4a9f7644afcb22c9b
ToppCell10x5'-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue

GRIN1 PTPRF CRABP1

4.15e-0418136394680f8dbdf22d83801abc0819417751d363fb12
ToppCell3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GRIN1 CRABP1 NCS1

4.21e-04182363be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CABP1 STX1A FAT3

4.21e-0418236314a117c5e50db31ee1b2cf4df4d133451fd6d55f
ToppCellE18.5-samps|World / Age Group, Lineage, Cell class and subclass

ISCA1 PTPRF CDH1

4.21e-041823639649f15858d1ede73e068afc59df3ac367b49687
ToppCelldroplet-Lung-nan-21m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100G PTPRF CDH1

4.21e-0418236340539ade8c3cd12b61f1cd0d493828e58282796b
ToppCelldroplet-Lung-LUNG-1m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100G PTPRF CDH1

4.21e-04182363c1e0be27064e14043b78ae501b02d4e9542267a3
ToppCelldroplet-Lung-LUNG-1m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100G PTPRF CDH1

4.21e-041823633c9b4869d357884ae4bcd22a9872faf83a5cfc6d
ToppCellPND07-28-samps-Epithelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass

S100G PTPRF CDH1

4.28e-04183363a98f1d71d82ed6cca996f74352ab834fb6e95206
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK7 CRABP1 MSI2

4.28e-041833632f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCellPND07-28-samps-Epithelial-Alveolar_epithelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass

S100G PTPRF CDH1

4.28e-0418336323e55f88a802a9299d2773f9394970e86e8bbfaa
ToppCellILEUM-inflamed-(5)_IgA_plasma_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

JUN ABCB9 P4HB

4.28e-04183363a113558ca4220bac31f9336033dff82a618d9258
ToppCellPND07-28-samps-Epithelial-Alveolar_epithelial-AT2|PND07-28-samps / Age Group, Lineage, Cell class and subclass

S100G PTPRF CDH1

4.28e-041833630a69e22750dd8b66ab988cf36d0dd2b59e2f7d26
ToppCelldroplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CRABP1 CDH1 FAT3

4.35e-041843636388c47b7f1d8203e3069eba0e74107256dcae51
ToppCellP28-Epithelial|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

4.35e-0418436305811d13bd8a602095a3fcf5e55345edadc7b8bf
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

S100G PTPRF CDH1

4.35e-0418436349705c8fec565b16216bdf48e83e27521f52d99a
ToppCelldroplet-Heart-4Chambers-18m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CRABP1 CDH1 FAT3

4.35e-04184363d83ae1dc64aa1b27d3b524c137567418cc0ff8c6
ToppCellfacs-Lung-EPCAM-18m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100G PTPRF CDH1

4.35e-0418436304bd8ab5808fcfa923aa4d0edf6a7f88b7980122
ToppCellfacs-Lung-EPCAM-18m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100G PTPRF CDH1

4.35e-04184363e727bf110cb6a91a655c1865b0e93e51e2f9dda3
ToppCelldroplet-Lung-nan-21m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100G PTPRF CDH1

4.42e-041853630e7351cd6d6e6e8c29573042e168da50ee496cfc
ToppCellPND01-03-samps-Epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass

S100G PTPRF CDH1

4.42e-041853632b854df79cfe2cb4d2f9c2938a066e0aa3649325
ToppCelldroplet-Lung-nan-21m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100G PTPRF CDH1

4.42e-041853636938ac3cab536cf8a474eba441ce6dcdfcc43b53
ToppCellP28-Epithelial-alveolar_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

S100G PTPRF CDH1

4.42e-041853635bb513e569f3a197d55ae2ca683e202daebabeac
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CRABP2 CDH1 FAT3

4.42e-04185363a6874dd3030d04380cc3c01de1069461aad4ef45
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

S100G PTPRF CDH1

4.42e-041853632adb32096aa3473f8d417e5ce9e65264beca9b52
ToppCellILEUM-non-inflamed-(5)_IgG_plasma_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

ABCB9 P4HB MSI2

4.42e-0418536393b9a47357152ea95dfdfe8e7d111906a4adc551
ToppCellnormal_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass

JUN ABCB9 P4HB

4.49e-04186363f4d72463c5f287da6436287eda0a349b4185841e
ToppCellNS-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

YBX3 NCKAP1 CDH1

4.49e-04186363c28f62524637c7eb9c43c9ec38fb12dfec6f5566
ToppCellfacs-Lung-EPCAM-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100G PTPRF CDH1

4.49e-041863633c4994a1a7db06a61da8170e45e06aaef7896592
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CABP1 STX1A FAT3

4.49e-0418636384ba666237c18189d7e7556bd92dd953af733c00
ToppCellfacs-Lung-EPCAM-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100G PTPRF CDH1

4.49e-041863637c4eb769574f9f32753cea1cc38c711dabba88b9
DrugAC1O5SCP

RARS1 CRABP1

2.43e-062362CID006439759
DrugAC1O5SCS

RARS1 CRABP1

2.43e-062362CID006439761
Drugmethyl arotinoid

RARS1 CRABP1

2.43e-062362CID006435155
Drugethyl sulfone

RARS1 CRABP1

2.43e-062362CID000069004
Drug3,4-didehydroretinoic acid

RARS1 CRABP1 CRABP2

2.91e-0618363CID000447276
Drugadapalene

RARS1 CRABP1 CRABP2

5.48e-0622363CID000060164
DrugAC1L32JQ

RARS1 CRABP1 CRABP2

6.29e-0623363CID000133319
DrugCcris 5341

TXN2 P4HB

1.46e-054362CID003034823
DrugSRI 5898-21

RARS1 CRABP1

1.46e-054362CID006439757
DrugCD367

RARS1 CRABP1 CRABP2

1.92e-0533363CID000119342
DrugAC1O5TI3

RARS1 CRABP1

2.42e-055362CID006440391
Drugsumarotene

RARS1 CRABP1

2.42e-055362CID006436127
DrugCd2366

JUN RARS1

2.42e-055362CID006443796
DrugRo 41-5253

RARS1 CRABP1 CRABP2

2.72e-0537363CID005312120
Drugliarozole

RARS1 CRABP1 CRABP2

3.19e-0539363CID000060652
Drugtazarotene

RARS1 CRABP1 CRABP2

3.45e-0540363CID000005381
DrugDB02258

JUN CRABP1

3.63e-056362CID009887303
DrugCD270

RARS1 CRABP1

3.63e-056362CID000175968
DrugAGN 191659

RARS1 CRABP1

5.08e-057362CID006366726
DrugRA-3

RARS1 CRABP1

5.08e-057362CID005745995
DrugAGN 190121

RARS1 CRABP1

5.08e-057362CID006441236
Drugetarotene

RARS1 CRABP1

6.77e-058362CID006435463
Drugretinyl methyl ether

JUN RARS1

8.69e-059362CID006436634
Drugtellurium dioxide

YBX3 STX1A TXN2

1.00e-0457363CID000062638
DrugAC1L2E0P

JUN RARS1 CRABP1 CRABP2 CDH1

1.15e-04307365CID000019390
DrugBD 1047

JUN GRIN1

1.32e-0411362ctd:C097963
DrugAGN 191701

RARS1 CRABP1

1.32e-0411362CID006438168
Drugmorusin

JUN CDH1

1.59e-0412362ctd:C057451
Drugdiethyl disulfide

STX1A P4HB

1.59e-0412362CID000008077
DrugSTA2

STX1A MYL3 RARS1

1.70e-0468363CID005311453
Drugiodoacetamide

RARS1 TXN2 P4HB TSFM

1.87e-04181364CID000003727
Drugtazarotenic acid

RARS1 CRABP1

1.88e-0413362CID000147525
DrugRo 13-6298

RARS1 CRABP1

1.88e-0413362CID006437076
DrugAC1L1DMQ

RARS1 CRABP1

2.19e-0414362CID000002418
Drugdinitroglycerol

RARS1 P4HB

2.19e-0414362CID000079076
DrugAC1O43PA

JUN TERF1

2.19e-0414362CID006323294
Drugrosiglitazone maleate; Up 200; 10uM; PC3; HG-U133A

JUN UBE3A NCS1 TSFM

2.29e-04191364430_UP
DrugCarbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A

JUN PTPRF CDH1 UBE3B

2.34e-041923644110_DN
Drugtroglitazone; Down 200; 10uM; HL60; HT_HG-U133A

JUN EFCAB14 UBE3A NCS1

2.34e-041923641173_DN
DrugTocopherols

JUN STX1A GRIN1

2.45e-0477363ctd:D024505
Drug4-oxoretinoic acid

RARS1 CRABP1 CRABP2

2.45e-0477363CID006437063
Drug4-OH-2',3,3',4',5'-pentachlorobiphenyl

JUN P4HB

2.52e-0415362ctd:C501474
Drugestradiol, USP; Down 200; 0.01uM; ssMCF7; HG-U133A

STX1A GRIN1 CRABP1 SNX6

2.53e-04196364373_DN
Drughaloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA

JUN PTPRF NCKAP1 CCNK

2.53e-041963641082_UP
DrugBuflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A

JUN ABCB9 CDH1 UBE3B

2.53e-041963644840_DN
DrugRibostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; PC3; HT_HG-U133A

STX1A NCKAP1 UBE3A TSFM

2.53e-041963647123_DN
DrugAC1L1KPQ

RARS1 CRABP1 CRABP2

2.55e-0478363CID000005602
DrugLevamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; HL60; HG-U133A

SNX3 EFCAB14 UBE3A CETN3

2.58e-041973641410_DN
DrugPapaverine hydrochloride [61-25-6]; Down 200; 10.6uM; MCF7; HT_HG-U133A

JUN STX1A CRABP1 NCS1

2.58e-041973642747_DN
DrugMesalamine [89-57-6]; Down 200; 26.2uM; MCF7; HT_HG-U133A

STX1A ABCB9 CCNK TSFM

2.58e-041973643584_DN
DrugBenzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A

JUN RARS1 NCS1 TSFM

2.58e-041973645811_DN
DrugOxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HG-U133A

JUN SNX3 EFCAB14 NCKAP1

2.58e-041973641903_DN
DrugPanthenol (D) [81-13-0]; Down 200; 19.4uM; PC3; HT_HG-U133A

JUN STX1A RARS1 CDH1

2.63e-041983641802_DN
DrugIsoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A

JUN STX1A CDH1 UBE3B

2.63e-041983642246_DN
DrugRiluzole hydrochloride; Down 200; 14.8uM; HL60; HT_HG-U133A

JUN RARS1 TSFM UBE3B

2.63e-041983642334_DN
DrugOxaprozin [21256-18-8]; Up 200; 13.6uM; PC3; HT_HG-U133A

SEMA6C GRIN1 MYL3 CRABP1

2.68e-041993643794_UP
DrugStachydrine hydrochloride; Down 200; 22.2uM; HL60; HG-U133A

JUN RARS1 UBE3A UBE3B

2.68e-041993641751_DN
DrugAzathioprine [446-86-6]; Down 200; 14.4uM; HL60; HG-U133A

JUN SNX3 EFCAB14 UBE3A

2.68e-041993642028_DN
Drugrosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A

JUN ABCB9 CRABP1 TSFM

2.68e-041993646950_DN
DrugRamipril [87333-19-5]; Down 200; 9.6uM; HL60; HT_HG-U133A

JUN CRABP2 TSFM UBE3B

2.73e-042003646150_DN
Drugdacthal

MYL3 P4HB

2.88e-0416362CID000002943
Drugantroquinonol

JUN CDH1

3.26e-0417362ctd:C545357
Drug3,4',5-trimethoxystilbene

JUN CDH1

3.26e-0417362ctd:C497286
Drugtamibarotene

RARS1 CRABP1 CRABP2

3.39e-0486363CID000108143
DrugHX600

RARS1 CRABP1

3.66e-0418362CID000128016
Diseasethyroxine measurement, triiodothyronine measurement

RARS1 ABCB9

1.95e-0417362EFO_0005130, EFO_0008392
Diseaselate-onset Alzheimers disease

ZNF462 TXN2 CDH1 FAT3

4.31e-04292364EFO_1001870
Diseaseapolipoprotein A 1 measurement

DOCK7 BBS2 MYL3 ABCB9 CDH1 TSFM

5.16e-04848366EFO_0004614
DiseaseCombined oxidative phosphorylation deficiency

TXN2 TSFM

9.38e-0437362cv:C4540031
Diseasetriglyceride measurement, C-reactive protein measurement

CABP1 S100G

9.90e-0438362EFO_0004458, EFO_0004530
Diseasehealth study participation

CABP1 S100G PTPRF

1.73e-03195363EFO_0010130
Diseasetriglycerides in medium VLDL measurement

DOCK7 STX1A

2.06e-0355362EFO_0022155
DiseaseIntellectual Disability

ZNF462 SNX3 GRIN1 RARS1

2.09e-03447364C3714756
Diseasetriglycerides in very large VLDL measurement

DOCK7 STX1A

2.14e-0356362EFO_0022325
Diseasetriglycerides in large VLDL measurement

DOCK7 STX1A

2.14e-0356362EFO_0022178
Diseasetriglycerides in VLDL measurement

DOCK7 STX1A

2.37e-0359362EFO_0022326

Protein segments in the cluster

PeptideGeneStartEntry
DVQFGQFGDDPKEEV

CCNK

126

O75909
VDLNGDGRVDFEEFV

CABP1

351

Q9NZU7
EEEEEFGVVGNRSRF

EFCAB14

46

O75071
RGFGFVTFENEDVVE

MSI2

151

Q96DH6
TTEINFKVGEGFEEE

CRABP1

61

P29762
FKVGEGFEEETVDGR

CRABP1

66

P29762
FKVGEEFEEQTVDGR

CRABP2

66

P29373
GDSDEEVIQDGVRVF

ISCA1

71

Q9BUE6
GKREFVEDGEVDESD

MAK16

216

Q9BXY0
VFDENKDGRIEFSEF

NCS1

71

P62166
EDFVEGLRVFDKEGN

MYL3

131

P08590
KNVTDEQEGFAEGFV

JUN

101

P05412
SVVDFVRFECGEGEE

TSFM

306

P43897
FKKFDEGRNNFEGEV

P4HB

206

P07237
SVKQVEDGEVFDFRG

NCKAP1

471

Q9Y2A7
VGSEDFDIRVFKEDE

BBS2

181

Q9BXC9
YGERFGEDVVEVIKD

DOCK7

1881

Q96N67
GDEEGFFKAEEVIIA

FAT3

86

Q8TDW7
FDKDGDGEINQEEFI

CETN3

146

O15182
IDDFSEVRGVEFDDK

GRK7

486

Q8WTQ7
EVRGVEFDDKDKQFF

GRK7

491

Q8WTQ7
KRVEVSEDFGVGQEI

CDH1

491

P12830
QRFEVIEFDDGAGSV

PTPRF

76

P10586
VKEFEDRGFVQVDDG

RARS1

346

P54136
GDGEVSFEEFQVLVK

S100G

61

P29377
QGVGAAEKVFEFIDR

ABCB9

471

Q9NP78
NGDVVDKFVGIKDED

TXN2

141

Q99757
DEGGVSKEFFQLVVE

UBE3A

566

Q05086
VEFDVVEGEKGAEAA

YBX3

141

P16989
EDVIEGVRNLFAEEG

GTF2A1L

16

Q9UNN4
DEFFEQVEEIRGFID

STX1A

31

Q16623
LDEIERGFEGKFKEQ

SEMA6C

336

Q9H3T2
ENGNFKEAEEVFERI

TERF1

186

P54274
DDGIFDDNFIEERKQ

SNX3

106

O60493
DGVIVSGVKDVDDFF

SNX6

196

Q9UNH7
DEAGIDQDGVFKEFL

UBE3B

721

Q7Z3V4
RGNFEKAEVEGEAQE

ZNF462

1826

Q96JM2
LGAQVEEDRTEFKEF

nan

26

A6NHS1
FGRFKVNSEEEEEDA

GRIN1

586

Q05586